Clinical Guideline Alerts – May 2024
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2024 Guideline Central, All rights reserved.
Guideline Central Blog
Alerts
Upcoming FDA Decisions – June 2024
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]
Amyotrophic Lateral Sclerosis (ALS) Guidelines – What’s Changed
Amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease, is a neurological disorder that impacts the motor neurons responsible for controlling voluntary muscle movement and breathing, according to the National Institutes of Health (NIH). The Centers for Disease Control and Prevention (CDC) has reported that at least 16,000 Americans are affected by ALS. […]
Urology – Guidelines+ Journals Rundown (May 2024)
In this post, we will be taking a closer look at some of the most popular urology-related articles recently published across medical journals. Current and Emerging Strategies to Curb Antibiotic-Resistant Urinary Tract Infections A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria. The Safe Testing of Risk for Asymptomatic […]
Enhertu® Metastatic Breast Cancer Trial Results DESTINY-Breast06
According to the National Institutes of Health (NIH), around 13% of women will receive a cancer diagnosis at some stage in their lives. In 2021, an estimated 3,972,256 women were living with cancer in the United States. The most prevalent cancer subtype is HR+/HER2-, with an age-adjusted rate of 90 new cases per 100,000 women, […]
New 2024 ACP Diabetes Guidelines and the Removal of DPP4s – Guidelines Spotlight
The American College of Physicians (ACP) released a new clinical guideline on April 19, 2024, for Newer Pharmacologic Treatments in Adults With Type 2 Diabetes. This guideline focused specifically on three classes of medications commonly used for patients with Type 2 Diabetes Mellitus: While the guideline is relatively short, consisting of only three key recommendations, […]
Healthcare News & Research – May 2024
Welcome to our succinct summaries of the most recent healthcare news and research. Keep yourself informed with our easily digestible updates sourced from medical media and news outlets. Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men: Individual Participant Data Meta-analyses Study Details | Source Consumption of Olive […]
Schizophrenia in Adults – Guidelines+ Trials Rundown
Today we’re going to look at the ongoing studies and clinical trials specific to management of schizophrenia in adults, including in acutely psychotic people with schizophrenia and relapse prevention. The below list was curated by assessing the ongoing Phase 3 trials for migraine treatments, specific for adults, and based in the United States. The dates […]
New Lower Extremity Peripheral Artery Disease Guidelines 2024 – What’s Changed and Key Takeaways
The 2024 AHA/ACC Guideline on the Management of Lower Extremity Peripheral Artery Disease has been officially released today. This new guideline serves as an update to the previous “2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease,” incorporating the latest evidence to assist clinicians in providing comprehensive care for patients […]
Dermatology – Guidelines+ Journals Rundown (May 2024)
In this post, we will be taking a closer look at some of the most popular dermatology-related articles recently published across leading medical journals. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data Oral Minoxidil vs Topical Minoxidil for […]
Comparing Five Current Hepatocellular Carcinoma Clinical Guidelines – Guidelines Side-By-Side Series
For the next installment of our Guidelines Side-By-Side series, we’re going to take a look at the current guidelines for liver cancer. This article will examine how the recommendations in each guideline agree, contradict, or otherwise differ. Our topic for today will be systemic treatment for metastatic hepatocellular carcinoma. The focus will be limited to […]
New Clinical Practice Guidelines & FDA Approvals – April 2024
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Upcoming FDA Decisions – May 2024
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug or device applications. Below, you will find a list of drugs and devices, […]
Endocrinology – Guidelines+ Journals Rundown (April 2024)
In this post, we will be taking a closer look at some of the most popular endocrinology-related articles that have been published during the month of April 2024. The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report 2024 Abridged Diabetes Standards of Care Impact of insulin sensitization […]
New FDA Medication Approval – Anktiva for NMIBC
On April 22, 2024, the US Food and Drug Administration (FDA) approved ImmunityBio’s first-in-class interleukin-15 superagonist (IL-15) nogapendekin alfa inbakicept-pmln (Anktiva), plus bacillus Calmette-Guérin (BCG), for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors. Designated an FDA Breakthrough Therapy, the novel immunotherapy […]
New Clinical Practice Guidelines & FDA Approvals – March 2024
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – February 2024
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – January 2024
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – December 2023
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – November 2023
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – October 2023
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – September 2023
Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia Author:American College of Obstetricians and Gynecologists (ACOG) Published:September 1, 2023 Outpatient Treatment of Confirmed COVID-19 Author:American College of Physicians (ACP) Published:September 19, 2023 Optimal Timing of Elective Hip or Knee Arthroplasty for Patients with Symptomatic Moderate to Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis with Secondary Arthritis […]
New Clinical Practice Guidelines & FDA Drug Approvals – August 2023
Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication Author:United States Preventive Services Task Force (USPSTF) Published:August 2023 Prevention of Acquisition of HIV: Preexposure Prophylaxis Author:United States Preventive Services Task Force (USPSTF) Published:August 2023 Palliative Care for People with Chronic Obstructive Pulmonary Disease or Interstitial Lung Disease Author:European Respiratory Society (ERS) Published:August 17, 2023 […]
New Clinical Practice Guidelines & FDA Drug Approvals – July 2023
Lipid Disorders in Children and Adolescents: Screening Author:United States Preventive Services Task Force (USPSTF) Published:July 2023 Implementing Strategies to Prevent Infections in Acute-Care Settings Author:Infectious Diseases Society of America (IDSA); Society for Healthcare Epidemiology of America America (SHEA) Published:July 11, 2023 Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy Author:American Society of Clinical Oncology (ASCO) […]
New Clinical Practice Guidelines & FDA Drug Approvals – June 2023
Anxiety Disorders in Adults: Screening – Adults 64 Years or Younger Author:United States Preventive Services Task Force (USPSTF) Published:June 2023 Anxiety Disorders in Adults: Screening – Older Adults 65 Years or Older Author:United States Preventive Services Task Force (USPSTF) Published:June 2023 Depression and Suicide Risk in Adults: Screening – Adults 64 Years or Younger Author:United […]